Davis Polk & Wardwell and Paul Hastings LLP are advising Francisco Partners and TPG, and Latham & Watkins LLP is advising New Relic on the transaction....
Francisco Partners and TPG’s $6.5 Billion Acquisition of New Relic
Cadence’s Acquisition of Rambus PHY IP Assets
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
Fortrea Holdings’ $1.52 Billion Credit Facilities
Cahill represented the lead arrangers in the financing. Fortrea Holdings announced a $500,000,000 term A credit facility, a $570,000,000 term B credit facility and a $450,000,000...
TA Associates Strategic Growth Investment in Alpha II
Latham & Watkins advises Alpha II and existing shareholder WestView Capital Partners on TA Associates strategic Growth investment. TA Associates, a leading global private equity firm,...
NextRoll’s $50 Million Financing Deal From Capital IP
Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
Guardant Health’s Upsized Public Offering of Common Stock
Latham & Watkins Advises Guardant Health in Pricing of Upsized Public Offering of Common Stock. Guardant Health, Inc., a leading precision oncology company, has announced the pricing...
Intapp’s $228 Million Public Offering of Common Stock
Proskauer Rose advised Intapp, Latham & Watkins advised the underwriters, Sidley Austin advised Great Hill Equity Partners IV, L.P. and its affiliates, and Morrison & Foerster...
Coherus BioSciences’ $57.5 Million Follow-On Offering
Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering. Coherus BioSciences, Inc. (“Coherus”, Nasdaq:...
4D Molecular Therapeutics’ $120 Million Common Stock Offering
Latham & Watkins advised 4D Molecular Therapeutics, while Cooley advised the underwriters for the offering. 4D Molecular Therapeutics, Inc. has announced that it priced an upsized...
Alongside’s $11 Million Financing Round
Pillsbury advised Alongside on the deal. Alongside Finance, Inc. (“Alongside”) has raised $11 million from investors including a16z crypto, Coinbase Ventures and Franklin Templeton. Committed to...
Vue Storefront’s $20 Million Equity Financing Round
Pillsbury advised Vue Storefront Inc. on the deal. Vue Storefront Inc. (“Vue”), a global technology startup for ecommerce businesses, in its recent $20 million equity financing...
IDEAYA Biosciences’ $175 Million Common Stock Public Offering
Latham & Watkins represents IDEAYA Biosciences in the offering. IDEAYA Biosciences, Inc. (Nasdaq:IDYA) has announced the pricing of an underwritten public offering of common stock and...